SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-046414
Filing Date
2015-02-12
Accepted
2015-02-12 14:40:06
Documents
2
Group Members
PUBLIC JOINT STOCK CO PHARMSTANDARD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d869932dsc13g.htm SC 13G 59040
2 EX-99.1 d869932dex991.htm EX-99.1 4989
  Complete submission text file 0001193125-15-046414.txt   65508
Mailing Address 200 WEST STREET WALTHAM MA 02451
Business Address 200 WEST STREET WALTHAM MA 02451 781-890-0102
PROTEON THERAPEUTICS INC (Subject) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88372 | Film No.: 15605215
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13G